Follow
Jin-Fen Xiao
Jin-Fen Xiao
Verified email at cshs.org
Title
Cited by
Cited by
Year
Advances in bladder cancer biology and therapy
L Tran, JF Xiao, N Agarwal, JE Duex, D Theodorescu
Nature Reviews Cancer 21 (2), 104-121, 2021
4302021
Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma
YY Jiang, DC Lin, A Mayakonda, M Hazawa, LW Ding, WW Chien, L Xu, ...
Gut 66 (8), 1358-1368, 2017
1952017
Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression
Y Jiang, YY Jiang, JJ Xie, A Mayakonda, M Hazawa, L Chen, JF Xiao, ...
Nature communications 9 (1), 3619, 2018
1882018
SETDB1 accelerates tumourigenesis by regulating the WNT signalling pathway
QY Sun, LW Ding, JF Xiao, W Chien, SL Lim, N Hattori, L Goodglick, ...
The Journal of pathology 235 (4), 559-570, 2015
1062015
Mutational landscape of pediatric acute lymphoblastic leukemia
LW Ding, QY Sun, KT Tan, W Chien, AM Thippeswamy, A Eng Juh Yeoh, ...
Cancer research 77 (2), 390-400, 2017
932017
Selective inhibition of unfolded protein response induces apoptosis in pancreatic cancer cells
W Chien, LW Ding, QY Sun, LA Torres-Fernandez, SZ Tan, J Xiao, SL Lim, ...
Oncotarget 5 (13), 4881, 2014
892014
Ordering of mutations in acute myeloid leukemia with partial tandem duplication of MLL (MLL-PTD)
QY Sun, LW Ding, KT Tan, W Chien, A Mayakonda, DC Lin, XY Loh, ...
Leukemia 31 (1), 1-10, 2017
752017
RNA-Binding Protein ZFP36L1 Suppresses Hypoxia and Cell-Cycle Signaling
XY Loh, QY Sun, LW Ding, A Mayakonda, N Venkatachalam, MS Yeo, ...
Cancer research 80 (2), 219-233, 2020
452020
Combined inhibition of PD-1/PD-L1, Lag-3, and Tim-3 axes augments antitumor immunity in gastric cancer–T cell coculture models
K Mimura, LF Kua, JF Xiao, BR Asuncion, Y Nakayama, N Syn, Z Fazreen, ...
Gastric Cancer 24, 611-623, 2021
432021
SOX7 regulates MAPK/ERK-BIM mediated apoptosis in cancer cells
QY Sun, LW Ding, K Johnson, S Zhou, JW Tyner, H Yang, NB Doan, ...
Oncogene 38 (34), 6196-6210, 2019
432019
The c‐MYC–BMI1 axis is essential for SETDB1‐mediated breast tumourigenesis
JF Xiao, QY Sun, LW Ding, W Chien, XY Liu, A Mayakonda, YY Jiang, ...
The Journal of Pathology 246 (1), 89-102, 2018
352018
Targetable pathways in advanced bladder cancer: FGFR signaling
JF Xiao, AW Caliri, JE Duex, D Theodorescu
Cancers 13 (19), 4891, 2021
272021
LNK suppresses interferon signaling in melanoma
LW Ding, QY Sun, JJ Edwards, LT Fernández, XB Ran, SQ Zhou, ...
Nature communications 10 (1), 2230, 2019
232019
LNK (SH2B3): paradoxical effects in ovarian cancer
LW Ding, QY Sun, DC Lin, W Chien, N Hattori, XM Dong, S Gery, M Garg, ...
Oncogene 34 (11), 1463-1474, 2015
222015
Diagnosis and relapse: cytogenetically normal acute myelogenous leukemia without FLT3-ITD or MLL-PTD
W Chien, QY Sun, LW Ding, A Mayakonda, S Takao, L Liu, SL Lim, ...
Leukemia 31 (3), 762-766, 2017
132017
Profiling the B/T cell receptor repertoire of lymphocyte derived cell lines
KT Tan, LW Ding, QY Sun, ZT Lao, W Chien, X Ren, JF Xiao, XY Loh, ...
BMC cancer 18, 1-13, 2018
92018
Targeting RNA exonuclease XRN1 potentiates efficacy of cancer immunotherapy
XB Ran, LW Ding, QY Sun, H Yang, JW Said, L Zhentang, V Madan, ...
Cancer Research 83 (6), 922-938, 2023
62023
KDM6A depletion in breast epithelial cells leads to reduced sensitivity to anticancer agents and increased TGFβ activity
JF Xiao, LF Kua, LW Ding, QY Sun, KN Myint, XR Chia, N Venkatachalam, ...
Molecular Cancer Research 20 (4), 637-649, 2022
42022
Clonality and clonal evolution analysis of paediatric ALL based on B‐cell receptor/T‐cell receptor rearrangement.
LW Ding, KT Tan, QY Sun, ZT Lao, H Yang, N Jiang, W Chien, JF Xiao, ...
British Journal of Haematology 184 (5), 2019
32019
Metabolic targeting of cancer associated fibroblasts overcomes T-cell exclusion and chemoresistance in soft-tissue sarcomas
MT Broz, EY Ko, K Ishaya, J Xiao, M De Simone, XP Hoi, R Piras, B Gala, ...
Nature Communications 15 (1), 2498, 2024
22024
The system can't perform the operation now. Try again later.
Articles 1–20